News

Uterus transplant update: Fungal infection may have caused complication


 

References

The failure of the first U.S. uterus transplant may have been due a complication triggered by an infection of Candida, according to the Cleveland Clinic.

Surgeons perform the first uterus transplant in the United States. Courtesy the Cleveland Clinic

Surgeons perform the first uterus transplant in the United States.

“Preliminary results suggest that the complication was due to an infection caused by an organism that is commonly found in a woman’s reproductive system,” officials at the Cleveland Clinic said in an April 8 statement. “The infection appears to have compromised the blood supply to the uterus, causing the need for its removal. There is an ongoing review of all the data and the team is modifying the protocol to reduce the chances of this complication occurring again in the future. The health of our patient is and has always been our primary concern.”

A team of surgeons at the Cleveland Clinic performed the first U.S. uterus transplant on a 26-year-old woman with uterine factor infertility on Feb. 24, but had to remove the transplanted uterus several days later following a sudden complication. The transplant is part of a study aimed at achieving pregnancy in women with uterine factor infertility. The study is still ongoing.

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

Malpractice claims for small bowel obstruction costly, frequent for general surgeons
MDedge ObGyn
Endometriosis linked to higher CHD risk
MDedge ObGyn
Skip lymphadenectomy if SLN mapping finds low-grade endometrial cancer
MDedge ObGyn
The crushing of innovation for treating female pelvic floor disorders: A story of “lead or be led”
MDedge ObGyn
Robot-assisted laparoscopic myomectomy
MDedge ObGyn
Cesarean scar defect: What is it and how should it be treated?
MDedge ObGyn
Gynecologic oncologists often missing from pediatric pelvic evaluations
MDedge ObGyn
2016 Update on minimally invasive gynecologic surgery
MDedge ObGyn
FDA investigates Boston Scientific’s surgical mesh
MDedge ObGyn
FDA allows marketing of morcellation containment system
MDedge ObGyn